Advertisement

Topics

Basilea Pharmaceutica AG Company Profile

05:34 EDT 22nd June 2018 | BioPortfolio

Basilea Pharmaceutica AG is an independent biopharmaceutical company actively engaged in the discovery and development of innovative drugs for the treatment of bacterial infections, fungal infections and skin diseases associated with high unmet medical needs. Basilea focuses its resources and capabilities on the discovery, development and eventual marketing of innovative medicines. The company is headquartered in Basel, Switzerland.

Location

Grenzacherstrasse 487Postfach

Basel
CH-4005
Switzerland

Contact

Phone: 41 61 6061 111
Fax: 41 61 6061 112
Email: webmaster@basilea.com


News Articles [59 Associated News Articles listed on BioPortfolio]

Basilea Pharmaceutica AG: Basilea names Adesh Kaul as new member of its Management Committee

Basilea Pharmaceutica AG / Basilea names Adesh Kaul as new member of its Management Committee . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the con...

Basilea Pharmaceutica AG: Basilea ernennt Adesh Kaul zum neuen Mitglied der Geschäftsleitung

Basilea Pharmaceutica AG / Basilea ernennt Adesh Kaul zum neuen Mitglied der Geschäftsleitung . Verarbeitet und übermittelt durch Nasdaq Corporate Solutions. Für den Inhalt der Mitteilung ist der E...

Basilea Pharmaceutica GJ-Zahlen 2017: Finanzergebnisse deutlich verbessert

Bad Marienberg - Basilea Pharmaceutica AG (ISIN: CH0011432447, WKN: A0B9GA, Ticker-Symbol: PK5, SIX Swiss Ex: BSLN, NASDAQ OTC-Symbol: BPMUF) gab heute die Finanzergebnisse für das Geschäftsjahr 20....

Basilea Pharmaceutica AG: Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Argentina by Grupo Biotoscana

Basilea Pharmaceutica AG / Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Argentina by Grupo Biotoscana . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is sole...

Basilea Pharmaceutica AG: Basilea reports clinical phase 3 study start with antibiotic ceftobiprole in skin infections under BARDA contract

Basilea Pharmaceutica AG / Basilea reports clinical phase 3 study start with antibiotic ceftobiprole in skin infections under BARDA contract . Processed and transmitted by Nasdaq Corporate Solution...

Basilea Pharmaceutica (BSLN) - Strength in numbers

Edison Investment Research - Pharmaceutical & healthcare - Basilea Pharmaceutica: Basilea reported a definable FY17, as a multitude of licensing/distribution agreements announced in 2016/17 for launch...

Basilea Pharmaceutica AG: Basilea announces completion of the license agreement extension with Pfizer for antifungal Cresemba for China and Asia Pacific

Basilea Pharmaceutica AG / Basilea announces completion of the license agreement extension with Pfizer for antifungal Cresemba for China and Asia Pacific . Processed and transmitted by Nasdaq Corpo...

Basilea Pharmaceutica AG: Basilea gibt Markteinführung des Antibiotikums Zevtera (Ceftobiprol) in Argentinien durch Grupo Biotoscana bekannt

Basilea Pharmaceutica AG / Basilea gibt Markteinführung des Antibiotikums Zevtera (Ceftobiprol) in Argentinien durch Grupo Biotoscana bekannt . Verarbeitet und übermittelt durch Nasdaq Corporate So....

PubMed Articles [60 Associated PubMed Articles listed on BioPortfolio]

SYNTHESIS OF NOVEL 1,4,5,6,7,8-HEXAHYDROQUINOLINES OF POTENTIAL ANTIMICROBIAL ACTIVITY.

A number of 2,3-disubstituted-1-cyclohexyl 4-(3,4-dimethoxyphenyl-1,4,5,6,7,8)-hexahydroquinolines and 5-(3,4-dimethoxyphenyl-10-cyclohexyl-3,4,5,6,7,8,9,10-octahydro)-3H-pyrimido[4,5-b]quinolines wer...

Anti-retroviral drugs: current state and development in the next decade.

The pace of discovery of new antiretroviral (ARV) drugs has slowed, although the efficacy and safety of once-daily fixed dose combinations have been extensively investigated. Several traditional ARV d...

SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL SCREENING OF DIANDRINE A.

Synthesis of a proline-rich cyclic hexapeptide - diandrine A [VI] was accomplished by coupling of tetrapeptide unit Boc-Gly-Pro-Trp-Pro-OH with dipeptide unit Tyr-Phe-OMe followed by cyclization of li...

NEW PYRIDINE AND TRIAZOLOPYRIDINE DERIVATIVES: SYNTHESIS, ANTIMICROBIAL AND ANTIOXIDANT EVALUATION.

A novel series of pyridine and triazolopyridine derivatives have been synthesized (1-17) and characterized on the basis of their elemental analyses and spectral data. In vitro antibacterial, antifunga...

ANTIFUNGAL ACTIVITY OF THE ROOT EXTRACTS OF PULSATILLA PATENS AGAINST CANDIDA GLABRATA.

Plants from the genus of Pulsatilla produce a variety of secondary metabolites with biological activity. These species play a special role in herbal medicine and are used in traditional folk medicine ...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

The objective of this study was to investigate the effect of three different types of occlusive overlays on the drug delivery of Fentanyl Transdermal Systems, 25 mcg/h manufactured for Myl...

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

The objective of this study was to investigate the effect of clinical procedures on the drug delivery of Fentanyl Transdermal Systems, 25 mcg/h manufactured for Mylan Pharmaceuticals Inc. ...

Vaginal Misoprostol Before IUD Insertion in Women With Cesarean Scar

Groups of study: 120 candidates for Cu T 380A IUD insertion were enrolled in the study. They were divided into two groups: Group 1: Sixty women received 600 micrograms of misoprostol vagi...

Companies [7 Associated Companies listed on BioPortfolio]

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG is an independent biopharmaceutical company actively engaged in the discovery and development of innovative drugs for the treatment of bacterial infections, fungal infections ...

Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem...

Janssen Pharmaceutica N.V.

Aurora Biomolecules

Aurora Biomolecules is situated in the heart of Cambridge & specialises in polyclonal antibody production and peptide synthesis for academia, pharmaceutica and industry.anti-GFP antibodiesContract man...

Janssen Pharmaceutica N.V

We are part of the world’s largest healthcare company, Johnson & Johnson, and enjoy an international reputation for pharmaceutical innovation and quality. For instance, EPREX™ , a breakthrough in ...

More Information about "Basilea Pharmaceutica AG" on BioPortfolio

We have published hundreds of Basilea Pharmaceutica AG news stories on BioPortfolio along with dozens of Basilea Pharmaceutica AG Clinical Trials and PubMed Articles about Basilea Pharmaceutica AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Basilea Pharmaceutica AG Companies in our database. You can also find out about relevant Basilea Pharmaceutica AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...


Corporate Database Quicklinks



Searches Linking to this Company Record